Robert Sek
Investor @ Recursion Pharmaceuticals
Austin, United States
Robert Sek is a serial entrepreneur who works to apply technology to solve problems in various industries, from Healthcare to Marketing.
Last updated:
For AI agents: llms.txt
About Recursion Pharmaceuticals
Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS,that combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate our programs. We are a biotechnology company scaling more like a technology company.
Recursion Pharmaceuticals Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chris Gibson
Co-Founder & CEO
|
|||
Michael Secora
Chief Financial Officer
|
|||
Ben Mabey
CTO
|
|||
Blake Borgeson
Co-founder, Board Member
|
|||
Christopher Gibson
Interim Executive Advisor
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
